BioLineRx (BLRX) Shares Outstanding (2010 - 2025)
BioLineRx (BLRX) posted quarterly Shares Outstanding (Entity) of $3.1 billion for Q4 2025, up 105.76% year-over-year from $1.5 billion in Q4 2024, and down 5.44% quarter-over-quarter from $3.3 billion in Q3 2025.
BioLineRx (BLRX) Shares Outstanding (2010 - 2025) Analysis & Trends
BioLineRx's Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $3.1 billion for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 105.76% year-over-year to $3.1 billion; the TTM figure through Dec 2025 stood at $3.1 billion (up 105.76% YoY), while the FY2025 annual figure was $3.1 billion, up 105.76% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $3.1 billion, down from $3.3 billion in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $60.0 billion in Q3 2024, with the low at $1.5 billion in Q4 2024.
- The 5-year median for Shares Outstanding (Entity) is $26.0 billion (2022), against an average of $25.5 billion.
- The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) surged 217.1% in 2021, then sank 95.72% in 2024.
- BioLineRx's Shares Outstanding (Entity) stood at $24.1 billion in 2021, then grew by 16.75% to $28.1 billion in 2022, then gained by 24.47% to $35.0 billion in 2023, then tumbled by 95.72% to $1.5 billion in 2024, then surged by 105.76% to $3.1 billion in 2025.
- Business Quant data shows BLRX's Shares Outstanding (Entity) at $3.1 billion in Q4 2025, $3.3 billion in Q3 2025, and $3.0 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | BioLineRx | 7.21 Bn | 7.21 Bn | 154,000.00 | 2.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.47 Bn |
| Sep 30, 2025 | 2.61 Bn |
| Jun 30, 2025 | 2.37 Bn |
| Mar 31, 2025 | 2.22 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 47.98 Bn |
| Jun 30, 2024 | 47.90 Bn |
| Mar 31, 2024 | 43.46 Bn |
| Dec 31, 2023 | 38.53 Bn |
| Sep 30, 2023 | 37.16 Bn |
| Jun 30, 2023 | 36.92 Bn |
| Mar 31, 2023 | 36.92 Bn |
| Dec 31, 2022 | 30.96 Bn |
| Sep 30, 2022 | 29.63 Bn |
| Jun 30, 2022 | 28.61 Bn |
| Mar 31, 2022 | 28.61 Bn |
| Dec 31, 2021 | 26.52 Bn |
| Sep 30, 2021 | 28.34 Bn |
| Jun 30, 2021 | 26.77 Bn |
| Mar 31, 2021 | 22.38 Bn |